Daytona Street Capital’s Alpha Tau Medical DRTS Stock Holding History

Daytona Street Capital’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Hold	146,106	–	–	1.33%	23
2026 Q1	$1.04M	Sell	146,106 -5,121	-3%	-$36.2K	0.8%	35
2025 Q4	$749K	Buy	+151,227	New	+$637K	0.58%	41

Other funds holding DRTS

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return

FGG

Financial Guidance Group Palm Harbor, Florida $267M AUM 19.62% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Daytona Street Capital's DRTS Position: Q2 2026 in Review

Daytona Street Capital held its Alpha Tau Medical (DRTS) position steady in Q2 2026 at 146,106 shares worth $1.83M. The position accounts for 1.33% of the portfolio, ranked #23.

Daytona Street Capital first reported a position in DRTS in Q4 2025 and has held it in 3 quarters since. 27 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

Daytona Street Capital held 146,106 shares of Alpha Tau Medical worth $1.83M as of Q2 2026.
Daytona Street Capital left its Alpha Tau Medical share count unchanged in Q2 2026.
Alpha Tau Medical made up 1.33% of Daytona Street Capital's portfolio in Q2 2026, its #23 holding.
Daytona Street Capital first reported a position in Alpha Tau Medical in Q4 2025 and has held it in 3 quarters since.
27 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Daytona Street Capital's 13F filing for Q2 2026, filed 3 Aug 2026.